Lawton Alison Frances 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed Sep 13, 2023
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-09-11+6,500→ 6,500 totalExercise: $11.20Exp: 2033-09-10→ Common Stock (6,500 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer.